MW
Matt Winterman
Executive Vice President, Product Supply, Operations Strategy & Transformation Officer
PerrigoTherapeutic Areas
Perrigo Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ibuprofen Tablets 200 mg | Pain Relief / Fever Reduction | Approved |
| Acetaminophen (Extra Strength) | Pain Relief / Fever Reduction | Approved |
| Advantage® Non-GMO Infant Formula | Infant Nutrition | Approved |
| Minoxidil Topical Solution USP 5% | Hair Regrowth Treatment | Approved |
| Nicotine Polacrilex Lozenge 4 mg | Smoking Cessation | Approved |
| Loratadine Tablets 10 mg | Allergy Relief | Approved |
| Famotidine Tablets 20 mg | Heartburn Relief | Approved |
| Omeprazole Delayed Release Tablets 20 mg | Frequent Heartburn | Approved |
Leadership Team at Perrigo
PL
Patrick Lockwood-Taylor
President & Chief Executive Officer
CA
Charles Atkinson
Executive Vice President, General Counsel and Secretary
DB
David Ball
Executive Vice President, Chief Brand and Digital Officer
EB
Eduardo Bezerra
Executive Vice President and Chief Financial Officer
RK
Roberto Khoury
Executive Vice President & Chief Commercial Officer
AL
Abbie Lennox
Executive Vice President & Chief Scientific Officer
RW
Rob Willis
Executive Vice President & Chief Human Resources Officer